Trade QURE anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
uniQure N.V. (QURE) is trading at US$48.60, down 1.94% today as of Aug 28, 12:15 EDT. The company has a market capitalisation of US$3.36B. Over the past 52 weeks, QURE has traded between US$8.73 and US$71.50. On Syfe you can trade QURE with $0 commission and add it to your watchlist.
| Previous close | US$49.56 |
|---|---|
| Market cap | US$3.36B |
| 52-week range | US$8.73 – US$71.50 |
| Volume | 711.68K |
| Exchange | US |
Add to Watchlist
Set Price Alert
uniQure N.V.
uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.
Year: 2014
UniQure Q2 Net Loss Widens, Revenue Increases
Jul 29, 1:05 PM · MT Newswires
-- Earnings Flash (QURE) uniQure Posts Q2 Loss of $1.22 a Share, vs. FactSet Est of $0.82 Loss
Jul 29, 11:34 AM · MT Newswires
-- Earnings Flash (QURE) uniQure N.V. Reports Q2 Revenue $5.8M, vs. FactSet Est of $5.5M
Jul 29, 11:18 AM · MT Newswires
Uniqure Insider Sold Shares Worth $952,051, According to a Recent SEC Filing
Jul 7, 8:54 PM · MT Newswires
Uniqure Insider Sold Shares Worth $983,030, According to a Recent SEC Filing
Jul 2, 9:03 PM · MT Newswires
uniQure N.V. (QURE) stock is trading at US$48.60, -1.94% from the previous close of US$49.56.
The market cap for uniQure N.V. (QURE) stock is approximately US$3.36B.
The 52-week high for uniQure N.V. (QURE) stock is US$71.50.
The 52-week low for uniQure N.V. (QURE) stock is US$8.73.
uniQure N.V. (QURE) does not currently pay a dividend.
Stay on top of QURE
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
